Botox and Pregnancy: An Overview
Botox® (
botulinum toxin type A) is a prescription medication approved for various cosmetic and medical purposes. The drug may not be safe for use during pregnancy, although the full risks are unknown.
Botox and Pregnancy Category C
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
When given to pregnant mice and rats, Botox increased the risk of low fetal weight and delayed bone development. When given to pregnant rabbits, the drug caused miscarriages and birth defects. However, it seems that rabbits are rather sensitive to the effects of Botox.
Even though Botox has not been studied in any pregnant women, there have been cases when pregnant women have accidentally been exposed to botulinum toxin through food poisoning or other accidental exposures. These cases suggest that botulinum toxin does not cross the placenta to the baby, and there may be circumstances when the risks of using Botox in pregnancy are outweighed by the possible benefits. However, cosmetic use of the drug during pregnancy is generally not recommended.